Bayer/Onyx Nexavar Hits Sales Plateau After Rapid Initial Uptake
This article was originally published in The Pink Sheet Daily
Executive Summary
Aggressive clinical trial plan aims to add new indications, build Nexavar oncology franchise on kidney cancer success.